相关实验视频

Updated: Jul 16, 2025

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

与EBV相关的GLELC免疫疗法的前景:一个相对"热"的瘤微环境

Yanna Lei^1,2, Peng Cao^2,3, Xiufeng Zheng^1,2

¹Department of Gastric Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Cancer medicine

|September 21, 2023

概括

与胃腺癌相比,与爱斯坦-巴尔病毒相关的胃淋巴细胞类似癌 (EBVaGLELC) 呈现出增加的T细胞透和降低的血管生成. 这种"热"的瘤微环境表明,免疫疗法对EBVaGLELC患者的潜在疗效.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
胃肠病学胃肠病学

背景情况:

埃普斯坦-巴尔病毒 (EBV) 相关的胃淋巴细胞瘤样癌 (EBVaGLELC) 是一种罕见的胃癌亚型.
关于瘤微环境 (TME) 和最佳治疗策略的研究有限.

研究的目的:

为了研究EBVaGLELC.的免疫特征.
确定这种罕见的胃癌亚型的潜在治疗优势和治疗选择.

主要方法:

对13例EBVaGLELC和8例胃腺癌 (GAC) 的回顾性分析 (2019-2022年).
多复合免疫光染色 (mIF) 用于评估免疫细胞子集和瘤血管性.

主要成果:

与GAC相比,EBVaGLELC显示CD3+ T细胞,CD8+ T细胞和Treg细胞的透率明显更高.
血管新生似乎在EBVaGLELC中的强度低于GAC.
一名患有高级EBVaGLELC的患者通过组合治疗实现了持续的部分反应 (>34个月的PFS).

结论:

EBVaGLELC呈现出一个独特的,免疫透的 (
热的热的热的热的热的热.
) 有降低血管生成的TME.
这些特征支持在与EBV相关的GLELC中使用免疫检查点抑制剂 (ICI) 的理由.
EBVaGLELC患者可能从免疫疗法中受益,并且可能对抗血管性疗法的敏感性较低.

关键词:

埃普斯坦-巴尔病毒 (EBV) 相关的胃淋巴细胞上腺瘤样癌.血管新生是因为血管新生.胃腺癌胃腺癌胃腺癌瘤微环境是一个微环境.透到瘤中的淋巴细胞

更多相关视频

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Barrett Esophagus-II: Clinical Manifestations and Management

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...